Nexentis Technologies Inc.(NXTS)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-03-26 | Lee Eun Young 10% Owner | Sale | -127 | -0.03%479,524 | $1.35 | $172 | View SEC filing | |
| 2024-12-26 | Rosenbloom Ronen Director | Purchase | +50,000 | +344.83%64,500 | N/A | N/A | View SEC filing | |
| 2023-12-26 | Weiss Amitay Director | Purchase | +100,000 | +100.00%100,000 | N/A | N/A | View SEC filing | |
| 2023-12-26 | Rosenbloom Ronen Director | Purchase | +14,500 | +100.00%14,500 | N/A | N/A | View SEC filing | |
| 2023-12-26 | Kalifi Udi Ovadia Director | Purchase | +14,500 | +109.92%27,692 | N/A | N/A | View SEC filing | |
| 2023-12-26 | Berenstein Israel Yakov Director | Purchase | +14,500 | +100.00%14,500 | N/A | N/A | View SEC filing | |
| 2023-12-26 | Arbib Eliahou Director | Purchase | +14,500 | +100.00%14,500 | N/A | N/A | View SEC filing | |
| 2022-07-26 | Kalifi Udi Ovadia Director | Purchase | +27,692 | +100.00%27,692 | $3.25 | $90,086 | View SEC filing |
1-8 of 8